Bactericidal/permeability-increasing protein prevents mucosal damage in an experimental rat model of chronic otitis media with effusion

Infection and Immunity

Volumn 68, Issue 5, 2000, Pages 2992-2994

  Nell, Marja J ^a   Koerten, Henk K ^a   Grote, Jan J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CHRONIC OTITIS MEDIA; CONTROLLED STUDY; HISTOPATHOLOGY; MUCOCILIARY CLEARANCE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA TYPHIMURIUM; SCANNING ELECTRON MICROSCOPY; SEROUS OTITIS MEDIA;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EAR, MIDDLE; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MUCOUS MEMBRANE; OTITIS MEDIA WITH EFFUSION; RATS; RECOMBINANT PROTEINS;

EID: 0034063267     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.5.2992-2994.2000     Document Type: Article

References (15)

1. Bluestone, C. D., J. S. Stephenson, and L. M. Martin. 1992. Ten-year review of otitis media pathogenesis. Pediatr. Infect. Dis. J. 11:S7-S11.
2. DeMaria, T. F., B. R. Briggs, D. J. Lim, and N. Okazaki. 1984. Experimental otitis media with effusion following middle ear inoculation of nonviable H. influenzae. Ann. Otol. Rhinol. Laryngol. 93:52-56.
3. DeMaria, T. F., R. B. Prior, B. R. Briggs, D. J. Lim, and H. G. Birck. 1984. Endotoxin in middle-ear effusions from patients with chronic otitis media with effusion. J. Clin. Microbiol. 20:15-17.
4. 2I) in patients with hemorrhage due to trauma: results of a multicenter phase II clinical trial. J. Trauma InJ. Infect. Crit. Care 46:667-677.
5. Elsbach, P., and J. Weiss. 1993. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187:417-429.
6. Elsbach, P., and J. Weiss. 1998. Role of the bactericidal/permeability-increasing protein in host defence. Curr. Opin. Immunol. 10:45-49.
7. Giebink, G. S. 1992. Otitis media update: pathogenesis and treatment. Ann. Otol. Rhinol. Laryngol. 101:21-23.
8. Giroir, B. P., P. A. Quint, P. Barton, E. A. Kirsch, L. Kitchen, B. Goldstein, B. J. Nelson, N. I. Wedel, S. F. Carroll, and P. J. Scannon. 1997. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/ permeability-increasing protein in children with severe meningococcal sepsis. Lancet 350:1439-1443.
9. Hentzer, E. 1972. Ultrastructure of the middle ear mucosa in secretory otitis media. II. Mucous effusion. Acta Otolaryngol. 73:467-475.
10. Johnson, A. P., and T. J. Inzana. 1986. Loss of ciliary activity in organ cultures of rat trachea treated with lipo-oligosaccharide from Haemophilus influenzae. J. Med. Microbiol. 22:265-268.
11. Marra, M. N., M. B. Thornton, J. L. Snable, C. G. Wilde, and R. W. Scott. 1994. Endotoxin-binding and neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5. Crit. Care Med. 22:559-565.
12. Nell, M. J., and J. J. Grote. 1999. Structural changes in the rat middle ear mucosa due to endotoxin and eustachian tube obstruction. Eur. Arch. Otorhinolaryngol. 256:167-172.
13. Nell, M. J., and J. J. Grote. 1999. Endotoxin and TNF-alpha in middle ear effusions: in relation with upper airway infection. Laryngoscope 109:1815-1819.
14. Nonomura, N., Y. Nakano, Y. Satoh, O. Fujioka, H. Niijima, and M. Fujita. 1986. Otitis media with effusion following inoculation of Haemophilus influenzae type b endotoxin. Arch. Otorhinolaryngol. 243:31-35.
15. Shimooka, R., K. Yajin, and Y. Harada. 1983. SEM studies of the inflammatory changes of the middle ear mucosa. Auris Nasus Larynx 10:79-86.